ArticleNeuroepidemiology2026
Global Trends and Disparities in Early-Onset Dementia: Systematic Analysis and Projection from the Global Burden of Diseases 2021 Study.
Article in Neuroepidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEarly-onset dementia (EOD) is an escalating health concern with profound consequences for individuals and health systems. Clarifying its burden is crucial for guiding resources, advancing diagnosis and interventions, and shaping health policies.
objectiveThe aim of the study was to assess the global EOD burden based on the Global Burden of Diseases (GBD) 2021 Study.
methodsWe analyzed the incidence, prevalence, disability-adjusted life years (DALYs), and deaths from EOD of people aged 40-64 years, estimating age-standardized rates and average annual percentage change (AAPC) from 1990 to 2021. The Bayesian age-period-cohort (BAPC) model was utilized to project incidence from 2022 to 2030.
resultsFrom 1990 to 2021, EOD cases more than doubled globally, increasing in incidence from 0.64 to 1.38 million and in prevalence from 3.68 to 7.76 million. The global age-standardized incidence rate rose slightly from 61.22 to 64.74 per 100,000 (AAPC = 0.17%), with parallel increases in prevalence (AAPC = 0.09%), DALYs (AAPC = 0.08%), and deaths (AAPC = 0.07%). In 2021, East Asia and Tropical Latin America exhibited the highest incidence (>80/100,000), while high-income North America, East Asia, and Tropical Latin America exhibited the highest prevalence and DALY rates. The highest incidence and prevalence were in high-middle sociodemographic index (SDI) regions, while DALYs and deaths were greatest in middle SDI regions. Females generally had a higher EOD burden than males. Projections indicate minor fluctuations in age-standardized incidence rates to 2030.
conclusionThe global burden of EOD has increased due to population growth and aging, despite a relatively stable age-standardized incidence. Notable disparities were observed across sex, SDI levels, regions, and countries, which may be partially attributed to methodological heterogeneities. The escalating burden of EOD highlights the importance of globally raising public awareness, designing health policies, and providing better services to patients with EOD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.